Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Other financing activities (2018 - 2024)

MedWellAI (MWAI) has disclosed Other financing activities for 7 consecutive years, with $148455.0 as the latest value for Q3 2024.

  • On a quarterly basis, Other financing activities changed N/A to $148455.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $148455.0, a 13.91% increase, with the full-year FY2023 number at -$499300.0, down 143.99% from a year prior.
  • Other financing activities was $148455.0 for Q3 2024 at MedWellAI, up from $700.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $4.1 million in Q4 2021 to a low of -$2.2 million in Q3 2021.
  • A 4-year average of $214040.5 and a median of $65163.0 in 2022 define the central range for Other financing activities.
  • Biggest YoY gain for Other financing activities was 99.46% in 2023; the steepest drop was 99.46% in 2023.
  • MedWellAI's Other financing activities stood at $4.1 million in 2021, then tumbled by 96.81% to $129626.0 in 2022, then crashed by 99.46% to $700.0 in 2023, then soared by 21107.86% to $148455.0 in 2024.
  • Per Business Quant, the three most recent readings for MWAI's Other financing activities are $148455.0 (Q3 2024), $700.0 (Q2 2023), and $129626.0 (Q2 2022).